Lenvatinib Shows Efficiency in Delaying Thyroid Cancer Progression

February 13, 2015 4:40 AM

4 0

Lenvatinib Shows Efficiency in Delaying Thyroid Cancer Progression

Oral Lenvatinib has demonstrated its efficacy in delaying the progression of advanced thyroid cancer by upto 18 months as compared to just 4 months when patients were treated with a placebo, the findings of a new study have revealed. These findings have been published in the New England Journal of Medicine.

The researchers took in 392 patients from 21 countries for the study- all of them having thyroid cancer that had become resistant to radioactive iodine treatment. Of these, 261 patients were treated with Lenvatinib, while the remaining received a placebo.

Also read: Eurowings settles pay dispute with airline cabin crew

Read more

To category page

Loading...